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Abstract Through major research advances in the study of
cytoskeletal organization, an integrated view of the complexity
of this system has emerged. Recent findings on the microtubule-
interacting protein Mip-90, which associates with microtubules
and actin filaments in different cell domains, have shed light on
its roles in cytoskeletal regulation. In order to study structural
features of Mip-90, we sequenced several peptide fragments. A
comparative sequence analysis revealed a high degree of
similarity between the primary structure of this protein and the
human heat shock protein of 90 kDa (hsp-90). Taken together,
the present studies indicate the identity between Mip-90 and the
the L-isoform of hsp-90 (hsp-90L). Western blot assays with an
anti-hsp-90 monoclonal antibody showed cross-reactivity of hsp-
90 and Mip-90 affinity purified from HeLa cells. Furthermore,
the observed structural identity of Mip-90 with the hsp-90L was
sustained by immunoblot assays using monoclonal antibodies
that specifically recognize the K- and L-forms of hsp-90.
Comparative fingerprinting analysis, along with the evidence of
a remarkably similar biochemical behavior of both hsp-90 and
Mip-90 in different affinity chromatographic systems, supported
these observations. These studies, along with previous investiga-
tions, provide new data to elucidate the functional significance of
these interesting cellular components and its relationships with
other proteins linked to the cell architecture.
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1. Introduction
There is increasing evidence that microtubule-associated
proteins (MAPs) play a major role in regulating the interac-
tion patterns that de¢ne cytoskeleton organization [1,2]. How-
ever, the functional versatility of the cytoskeletal structure and
its involvement in morphogenetic events of cells suggests that,
besides MAPs, a complex set of proteins participates in mod-
ulating cytoskeleton organization at the spatial and temporal
levels [2^6]. In the search for novel microtubule-interacting
proteins of functional relevance, a 90 kDa protein, designated
Mip-90 was identi¢ed as a major soluble component in HeLa,
N2A neuroblastoma cells and human ¢broblasts [6]. Mip-90
associates reversibly with microtubules, and binds to the C-
terminal L(422^434) and L(434^442) tubulin fragments, com-
mon sites for the interaction of several MAPs [2]. In addition,
Mip-90 forms complexes with calmodulin in a Ca2-depend-
ent fashion [6]. Immuno£uorescence studies revealed co-local-
ization of this protein with microtubules in various domains
of interphase cells. Recent studies established that Mip-90
interacts with actin, a ¢nding that contributes to explain the
functional versatility of this protein, and its modulatory role
in the organization of the actin/microtubule networks [5].
In order to gain more information regarding Mip-90’s
structure we have sequenced isolated fragments of this pro-
tein. The peptide sequences showed 100% homology with
equivalent fragments of the L-form of human hsp-90 and a
lower similarity with fragments from the K-isoform [7]. This
¢nding was supported by: (a) Western blot assays using di¡er-
ent antibodies revealed cross-reactivity of Mip-90, puri¢ed
from HeLa cells, with the L-isoform of hsp-90; (b) compar-
ison of peptide maps of both proteins.
Hsp-90 is an abundant, essential, cytosolic protein (under
normal conditions), that increases signi¢cantly under stress
conditions [8,9]. Hsp-90 has been directly involved in a wide
variety of cell functions, including a chaperone activity for
conformational processing of proteins, modulation of steroid
receptors and association with the cytoskeleton [10^13]. The
present data open new avenues to further understand func-
tional aspects of hsp-90, especially in regard to di¡erential
roles of hsp-90 isoforms in modulating cytoskeletal interac-
tions. On the other hand, the data on the structural and im-
munological similarities between Mip-90 and hsp-90 provide a
background of information to re-examine structure-function
relationships of these important cellular proteins.
2. Materials and methods
2.1. Cell culture
HeLa cells were used as a source of Mip-90 and hsp-90 for the
biochemical and immunological studies. The human ¢broblasts cells
used throughout immuno£uorescence studies were primary cultured
originated from samples of scrotal epithelium [5]. Cells were grown in
a 5% CO2 atmosphere, in 150-mm plastic tissue culture dishes, con-
taining 10 ml of Dulbecco’s modi¢ed Eagle’s medium supplemented
with 10% (v/v) fetal calf serum at 37‡C [5,6].
2.2. Protein puri¢cation
Mip-90 was puri¢ed as described previously [6]. The heat shock
protein hsp-90 was puri¢ed following the procedure of Welch and
Feramisco [14].
2.3. Antibodies
An a⁄nity-puri¢ed polyclonal antibody against Mip-90 was used
throughout these studies. The speci¢city of the antibody to Mip-90
has been shown in previous reports [5,6]. The monoclonal antibodies
against hsp-90 were obtained from Sigma Chemical Company (St.
Louis, MO, USA) and from StressGene (Biotechnology, Victoria,
B.C., Canada). Monoclonal antibodies that speci¢cally recognize
K- or L-isoforms of hsp-90 were kindly donated by Prof. Nemoto
(Iwate Medical University, Japan). Fluorescein-conjugated secondary
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antibody, mouse IgG against rabbit IgG, was obtained from Cappel
(Organon Teknika Corp, West Chester, PA, USA), and rhodamine-
conjugated rabbit IgG against mouse IgG was purchased from Sigma
Chemical Company (St. Louis, MO, USA). Peroxidase-conjugated
antibodies were obtained from Amersham Life Science (UK).
2.4. Sequence studies on Mip-90
Mip-90 fraction puri¢ed from calmodulin a⁄nity columns was
cleaved with a sequencing grade C-terminal lysine endoproteinase
(Promega, Madison, WI, USA) using a Protein Fingerprint System
(Promega). The fragment products were fractionated in 15% SDS-
polyacrylamide gels, electrotransferred into PDVF membranes and
stained with a solution of 50% methanol/Coomassie brilliant blue.
Single bands were cut and micro-sequenced using an Applied Biosys-
tems model 470A protein sequenator. The analysis of sequence ho-
mology was carried out by using the FASTA Program [15] and local
similarity Program LALIGN [16].
2.5. Peptide map analysis
Mip-90 and hsp-90 proteins were digested with lysine (Lys-C) and
glutamic (Glu-C) endoproteinases, using the Protein Fingerprint Sys-
tem (Promega), which is based on the procedure described by Cleve-
land et al. [17].
2.6. Western blot analysis
SDS-polyacrylamide gel electrophoresis was performed according
to the method of Laemmli [18]. For Western blot assays, PDVF
membranes were blocked in bu¡er TST (10 mM Tris, pH 8.0, 150
mM NaCl and 0.05% Tween 20) containing 3% BSA at room temper-
ature for 2 h, washed three times in TST and incubated 2^3 h with the
respective anti-Mip-90 or anti-hsp-90 antibodies diluted in TST/1%
BSA. The membranes were washed three times for 10 min each in
TST, and incubated at room temperature for 2 h with second anti-
bodies conjugated with horseradish peroxidase. A chemiluminescence
system (Amersham) or diaminobenzidine as the enzyme substrate
were used to detect bound antibodies [19].
2.7. Indirect immuno£uorescence studies
Cells grown on coverslips were permeabilized with 0.5% Triton X-
100 in microtubule assembly bu¡er (0.1 M MES, pH 6.8, 1 mM
EGTA and 1.5 mM MgCl2) for 1 min at room temperature and ¢xed
in methanol at 320‡C for 10 min as described [6]. Fixed cells were
incubated with PBS and incubated 1 h in blocking solution (1% BSA
in PBS). Cells were incubated with a⁄nity-puri¢ed polyclonal anti-
Mip-90 antibody (1:50) or monoclonal antibodies against hsp-90K
and hsp-90L as primary antibodies [20,21]. Fluorescein-conjugated
mouse IgG against rabbit IgG and rhodamine-conjugated rabbit
IgG against mouse IgG, previously centrifuged at 126 000Ug in a
Beckman Airfuge, were used as secondary antibodies. Cells were in-
cubated with primary or secondary antibodies for 1 h at room temper-
ature. Cells were rinsed in PBS, mounted in DABCO/Mowiol and
examined by conventional microscopy (100U objective, Carl Zeiss
Axiovert, Germany).
3. Results
In order to establish the identity of Mip-90, we microse-
quenced fragments of this protein. Puri¢ed Mip-90 was par-
tially digested with the lysine endoprotease that cleaves
C-terminal lysines in the polypeptide chain. Three of the se-
quenced fragments permitted an analysis of 8^10 amino acids
per fragment. A striking similarity between Mip-90 fragments
and the human hsp-90 protein was revealed in this analysis
(Fig. 1). The amino acid sequences of Mip-90 peptides
matched with sequences located in separate regions of the
Fig. 1. The upper part shows a schematic representation of the posi-
tions of the three Mip-90 sequenced fragments (shaded squares)
contained in the primary structure of hsp-90. The comparison of
Mip-90 sequenced fragments with the corresponding domains on the
hsp-90 K- and L-isoforms are shown in the lower part of the ¢gure.
The similarities of Mip-90 with each hsp-90 isoform are indicated in
terms of percentage homology relative to the respective hsp-90 se-
quences.
Fig. 2. Comparison of the peptide maps of proteolytic fragments
after digestion of puri¢ed Mip-90 (lane 1) and hsp-90 (lane 2) with
Lys-C endoproteinase. The arrow shows the additional band ob-
served in the hsp-90 proteolytic pattern and the arrowhead points
to a band that is enriched in the hsp-90 pattern. The relative molec-
ular weight standards (in kDa) are indicated at the left.
Fig. 3. Immunochemical characterization of a Mip-90, puri¢ed by
the calmodulin-agarose a⁄nity column, using anti-hsp-90L (lane 1),
anti-hsp-90K/L (lane 2), anti-hsp-90K (lane 3) monoclonal antibodies
and an anti-Mip-90 polyclonal antibody (lane 4). The calmodulin-
puri¢ed Mip-90 protein aliquots (5 Wg) were loaded and separated
in 10% acrylamide electrophoretic gels, electrotransferred onto nitro-
cellulose strips, and analyzed by Western blots using the di¡erent
antibodies. Other details are indicated in Section 2.
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primary structure of human hsp-90, based on hsp-90 se-
quences reported previously [7,22,23] (Fig. 1, shaded squares),
indicating that the similarity was not restricted to a unique
domain on hsp-90. This sequence comparison revealed the
identity of the three Mip-90 peptides with the L-form of the
hsp-90. Meanwhile the percentage of similarity with the K-
form of hsp-90 was only 60% and 67%, for the ¢rst and the
third Mip-90 peptides, respectively (Fig. 1). These peptides are
contained in regions of low homology between K- and L-iso-
forms of hsp-90. Thus, the data obtained from this set of
peptides indicate that Mip-90 corresponds to the L-isoform
of hsp-90.
Additional studies based on the chromatographic proce-
dures previously used to purify either Mip-90 [6] or hsp-90
[14], namely calmodulin a⁄nity columns and DEAE cellulose
and hydroxyapatite columns respectively, revealed that these
proteins shared common biochemical features (data not
shown), thus con¢rming their relationship at the protein pri-
mary structure level.
The structural relationship between Mip-90 and the puri¢ed
hsp-90 was further analyzed by examining peptide maps of
both proteins using the procedure of Cleveland et al. [17].
In spite of the high degree of similarity between the patterns
of proteolytic fragments generated by endoproteinase Lys-C
(Fig. 2) we observed some minor di¡erences. Thus, one pep-
tide band was enriched (arrowhead) and another speci¢cally
associated to hsp-90 (arrows). Studies using Glu-C endopro-
teinase also revealed a striking similarity of Mip-90 and hsp-
90 patterns. An analysis of Lys-C and Glu-C target sites,
using a protein digestion web service from the UCSF Mass
Spectrometry Facility (MSF), revealed several di¡erences be-
tween the K- and L-isoforms of hsp-90 in the number and
Fig. 4. Subcellular localization of (A,B) hsp-90K (C,D) hsp-90L and (E,F) Mip-90 as analyzed by an immuno£uorescence study in subcon£uent
human ¢broblasts cells. Monoclonal antibodies against hsp-90K- and L-isoforms, and a polyclonal antibody against Mip-90 were used. The spe-
ci¢city of the antibodies to hsp-90K and L components were characterized by Nemoto et al. [20,21] Cells were ¢xed and stained as indicated in
Section 2. Bar: 10 Wm.
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position of the digestion sites. Since the puri¢ed hsp-90 con-
tained both the K- and L-isoforms, the di¡erential bands ob-
served in the hsp-90 sample as compared with the Mip-90
pattern, could be a result of the presence of K-hsp-90.
Finally, immunological criteria were very important in or-
der to examine the identity of Mip-90 as the L-isoform of hsp-
90. In these studies, samples of Mip-90 eluted from a calmod-
ulin-agarose a⁄nity columns were used to challenge speci¢c
monoclonal antibodies against K- or L-isoforms of hsp-90
(Fig. 3). The Western blot analyses (n = 4) indicate that
Mip-90 was recognized by the monoclonal antibody against
hsp-90L (Fig. 3, lane 1), as well as by the antibody anti-hsp-90
K/L (Fig. 3, lane 2). A considerably minor reactivity was ob-
served with the anti-hsp-90K antibody (Fig. 3, lane 3). As a
control, the presence of Mip-90 was evidenced by using the
anti-Mip-90 antibody (Fig. 3, lane 4).
Taken together, the results clearly point toward a structural
identity between human Mip-90 and the L-form of heat shock
protein hsp-90. In this regard, it was interesting to evaluate
the subcellular distribution of hsp-90L and Mip-90. We exam-
ined the immunostaining patterns obtained with the monoclo-
nal antibodies against the K- and L-isoforms of hsp-90 as
compared with that of Mip-90. Human ¢broblasts were
used in this study considering that a detailed analysis on
Mip-90 organization has been done in these cells [5]. In per-
meabilized and methanol-¢xed cells, hsp-90L displayed a pref-
erential cytoplasmic distribution (Fig. 4C,D). A major frac-
tion of the immunostained protein was associated to
¢lamentous structures and appears to be preferentially local-
ized in a perinuclear network of ¢laments. These staining
features are comparable with those of the cytoplasmic distri-
bution of Mip-90 as assessed using the anti-Mip-90 antibody
(Fig. 4E,F). As indicated, previous studies have evidenced that
Mip-90 co-localizes with microtubules and actin ¢laments in
these cells [5]. In contrast, hsp-90K presents a more di¡use
immunostaining pattern and the protein distributes both in
the cytoplasm and in the nucleus (Fig. 4A,B). These results
are in agreement with the evidence of the structural similarity
between hsp-90L and human Mip-90.
4. Discussion
With the purpose of investigating the structural/functional
relationships of the human microtubule-interacting protein
Mip-90, the study was focused on the main structural charac-
teristics of this protein. Thus, the sequence of Mip-90 frag-
ments generated by partial proteolysis was analyzed. It was
noteworthy to ¢nd, after a comparative sequence analysis
with protein data banks, a high degree of similarity between
this human protein and the heat shock hsp-90. The data re-
vealed a complete identity between the three Mip-90 peptides
and the L-isoform of hsp-90. However, sequenced Mip-90
fragments 1 and 3 exhibited only 60^67% similarity with the
K-form of hsp-90 [7]. In agreement with this result, fragments
1 and 3 of Mip-90 are contained within hsp-90L regions that
show a low level of homology when compared to the hsp-90K
sequence. A relevant feature of sequenced Mip-90 fragments is
their co-alignment along equivalent sequences of hsp-90L
structure, indicating that the criteria of identity of these two
proteins is not restricted to a discrete domain conserved on
this protein, but rather distributed along N-terminal, C-termi-
nal and intermediate hsp-90 domains.
It was interesting to explore additional structural and im-
munological properties of Mip-90 to further examine its rela-
tionships with K- and L-forms of hsp-90. This analysis appears
to be important in the context of the functional relationships
between these two proteins. Mip-90 as well as hsp-90 reacted
with two di¡erent monoclonal antibodies against hsp-90.
Since it is unlikely that both antibodies recognize the same
epitope on Mip-90, these data suggest that its antigenic rela-
tionship with hsp-90 span di¡erent domains on the structure
of this protein. Moreover, the use of immunological probes
that speci¢cally recognize each isoform of hsp-90 [20,21] pro-
vides additional demonstration of the identity of Mip-90 as
the L-isoform of human hsp-90. The subcellular distribution
of hsp-90L seems to re£ect its structural identity with Mip-90.
Thus, a comparative analysis of hsp-90K- and L-isoforms dis-
tribution patterns is of help to clarify some discrepancies aris-
ing from previous studies on the immuno£uorescence local-
ization of hsp-90 to cytoskeletal ¢laments [10,24^28].
The data on peptide maps are consistent with structural
similarities between puri¢ed Mip-90 and hsp90K/L. The pres-
ence of di¡erent proteolytic fragments in the peptide map of
puri¢ed hsp-90, when compared with the Mip-90 pattern, may
re£ect the existence of distinctive sites for protease cleavage
on the K-hsp-90 component. Thus, the data allow us to sug-
gest that the minor di¡erences observed in the peptide maps
analyses seems to be related to the presence of both isoforms
in the pure hsp-90 preparation, while puri¢ed Mip-90 corre-
sponds only to the L-isoform of hsp-90. Even though there is
limited evidence for posttranslational modi¢cations in hsp-90
[8,29], the possibility that phosphorylations or other modi¢-
cations in hsp-90 may account for these minor di¡erences
cannot be discarded.
In the context of biochemical relationships between Mip-90
and hsp-90 the present studies reveal that hsp-90 under con-
ditions that maintain its native structure interacts with cal-
modulin in a similar fashion as Mip-90 [5,6]. Moreover, our
data suggest that native hsp-90 could be segregated in a
L-isoform with the capacity to associate calmodulin and in
an K-isoform with a diminished sensitivity to this cell regula-
tor. These di¡erences between hsp-90K and L may be a result
of distinct conformational pattern for both components, thus
de¢ning di¡erential associations of these isoforms with the
calmodulin a⁄nity matrix. As a methodological output of
this work, we suggest here the use of calmodulin-agarose
chromatography as a tool to purify the L-isoform of hsp-90.
Even though we cannot rule out the possibility that this cal-
modulin-interacting protein corresponds to a subclass of the
hsp-90L isoform, to date there is no evidence regarding mo-
lecular variants of hsp-90L [8].
Our studies have been focused on the identi¢cation and
analysis of novel microtubule-interacting proteins with rele-
vant functions on cytoskeletal organization. Within this con-
text Mip-90 was described as a protein that although it is
associated with microtubular polymers does not remain asso-
ciated with microtubules through successive cycles of assem-
bly and disassembly. Thus, previous data indicated that Mip-
90 transiently interacts with the tubulin/microtubule system
[6]. On the basis of the results reported in this work, and
our previous characterization of Mip-90 [5,6], an increasing
number of evidence regarding the relationship between hsp-90
and the cytoskeleton [10,24^28,30^32] can be reconciled. Since
in the cell, hsp-90 exists as homodimer of L/L- or K/K-isoforms
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[23^27], it is reasonable to propose that di¡erent isoforms
interact with di¡erent cell components. Particularly, our re-
sults suggest that the association of hsp-90 with microtubules
and micro¢laments can be re-examined, considering that our
data indicate that only the L-isoform of hsp-90 behaves as a
cytoskeleton-interacting protein. This possibility would be
evaluated in future experimental approaches.
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